Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Clementia Pharmaceuticals Inc. (CMTA)

13.51   -0.4 (-2.88%) 01-18 16:00
Open: 14.27 Pre. Close: 13.91
High: 14.7695 Low: 13.02
Volume: 34,115 Market Cap: 511M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 14.786 - 14.871 14.871 - 14.947
Low: 12.845 - 12.928 12.928 - 13.003
Close: 13.387 - 13.524 13.524 - 13.648

Technical analysis

as of: 2019-01-18 4:30:17 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. It is relatively safe to short or sell, downward move is expected.
Target: Six months: 17.25     One year: 20.15
Support: Support1: 12.29    Support2: 10.76
Resistance: Resistance1: 14.77    Resistance2: 17.25
Pivot: 13.04
Moving Average: MA(5): 13.51     MA(20): 12.75
MA(100): 12.11     MA(250): 13.64
MACD: MACD(12,26): 0.30     Signal(9): 0.15
Stochastic oscillator: %K(14,3): 79.69     %D(3): 76.52
RSI: RSI(14): 54.33
52-week: High: 19.58  Low: 8.10  Change(%): -22.8
Average Vol(K): 3-Month: 10668  10-Days: 4438

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
CMTA has closed below upper band by 35.7%. Bollinger Bands are 6.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-11-21T16:19:57-05:00
Clementia Pharmaceuticals: An Enduring Beacon Of Opportunity

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
atoplab.com
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 37.81
Shares Float (M) 37.81
% Held by Insiders
% Held by Institutions 75.30
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -1.590
EPS Est. Current Year -10.980
EPS Est. Next Year -1.340
EPS Est. Next Quarter
Forward EPS -1.370
Book Value (p.s.) 4.890
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -36.8
Return on Equity (ttm) -39.0
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -47.40
Levered Free Cash Flow (M) -26.12

Stock Valuations

P/E -8.50
P/E Growth Ratio -0.03
P/BV 2.76
P/S
P/CF -10.78

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.